source
- FDA approves Revolution Medicines’ pancreatic cancer drug Rasonque, but patients face delayed accessThe U.S. Food and Drug Administration has granted approval to Rasonque, a new therapy for pancreatic cancer developed by Revolution Medicines. The decision follows clinical data that showed the dru…
- Boston Scientific recalls spinal cord implant in wake of more than 1k serious injuriesBoston Scientific has issued another recall, this time for its spinal cord implant used to treat pain.Fierce Biotech · 5h ago↗ source